| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.68B | +10.5% |
| R&D Expense | $252.3M | +19.5% |
| SG&A Expense | $2.96B | +16.4% |
| Operating Income | $2.89B | +19.6% |
| Interest Expense | $234.5M | +4.9% |
| Pre-tax Income | $2.57B | +18.2% |
| Income Tax | $498.4M | +32.6% |
| Net Income | $2.02B | +15.2% |
| EPS (Basic) | $8.85 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.10B | -10.3% |
| Accounts Receivable | $2.96B | +6.4% |
| Inventory | $2.15B | +7.9% |
| Current Assets | $6.87B | +7.7% |
| Total Assets | $19.39B | +7.2% |
| Current Liabilities | $6.05B | +6.4% |
| Long-term Debt | $4.78B | -1.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.39B | +58.9% |
| Capital Expenditures | $300.7M | +3.1% |
| Investing Cash Flow | -$1.17B | -116.9% |
| Financing Cash Flow | -$1.35B | +27.1% |
| Free Cash Flow | $2.09B | +72.3% |
| +17.2% |
| EPS (Diluted) | $8.77 | +17.2% |
| Total Liabilities |
| $12.37B |
| +3.3% |
| Stockholders' Equity | $7.00B | +14.9% |